MedTrace Logo

The Bioequivalence Study of Acyclovir 800 mg Tablet in Healthy Thai Volunteers Under Fasting Conditions

NCT06228430 · Status: NOT_YET_RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2024-01-29

No results posted yet for this study

Summary

A Single Dose, Randomized, Open-label, Two-way Crossover Bioequivalence Study of Generic Acyclovir 800 mg Tablet and Reference Product (Zovirax™) in Healthy Thai Volunteers under Fasting Conditions

Conditions

  • Healthy Volunteer

Interventions

DRUG

Acyclovir 800 mg Tablet

Acyclovir 800 mg Tablet (Test Drug)

DRUG

Zovirax™ 800 mg Tablet

Zovirax™ 800 mg Tablet (Reference Drug)

Sponsors & Collaborators

  • International Bio service

    lead NETWORK

Principal Investigators

  • Uthai Suvanakoot · International Bio service

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-02-12
Primary Completion
2024-02-15
Completion
2024-02-22

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06228430 on ClinicalTrials.gov